Rheumatoid arthritis affects millions of Americans, gradually changing lives as it progresses from subtle joint discomfort to potentially severe mobility limitations. For those living with this ...

AbbVie Inc. said premarket Wednesday that its rheumatoid arthritis drug had positive results in a late-stage clinical trial. The drug, upadacitinib, is intended for patients with moderate to severe ...

NEW YORK (Reuters) - AbbVie Inc on Tuesday said its experimental rheumatoid arthritis (RA) treatment showed significant improvement in physical function, pain and quality of life compared with the ...

Eli Lilly and Co. said it discontinued a trial of an experimental rheumatoid arthritis drug for lack of efficacy. The trial, in the last stage of three generally required for regulatory approval, is ...

PHILADELPHIA -- Aimed at treating rheumatoid arthritis, an investigational antibody drug that stimulates checkpoint activity yielded good results in a phase II study reported here. After 12 weeks, ...

Features of immune system ageing can be detected in the earliest stages of rheumatoid arthritis (RA), even before clinical diagnosis, a new study has found which provides at-risk individuals with hope ...

Drugs used to treat initial signs of rheumatoid arthritis also improve the early stages of heart disease, according to new research. Having rheumatoid arthritis (RA) is known to at least double the ...

AstraZeneca ($AZN) announced an update on their ongoing clinical study. AstraZeneca Advances Mid-Stage Rheumatoid Arthritis Trial With AZD1163 ...

ANN ARBOR, MI, Aug 19, 2008 (MARKET WIRE via COMTEX) -- Pipex Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central ...

New research shows that a novel positron emission tomography (PET) tracer that targets inflammation is safe and can clearly identify early stages of rheumatoid arthritis. The promising PET tracer, ...

Eli Lilly & Co. LLY said Thursday a mid-stage trial of a treatment for rheumatoid arthritis met its main goal for efficacy with similar rates of adverse events between the treatment group and placebo ...

NEW YORK, Nov 7 Reuters) - A closely watched experimental drug for rheumatoid arthritis being developed by Pfizer Inc significantly reduced symptoms and improved physical function, according to data ...